Popular Diabetes Drug Avandia May Cause Osteoporosis

Recent research raises the possibility that rosiglitazone (also known as the drug Avandia), a popular diabetes drug used to improve the body’s response to insulin, may increase bone thinning and with long-term treatment could lead to osteoporosis. This discovery that could help to explain why diabetics can have an increased risk of bone fractures.